March 29, 2017 7:50 PM ET

Pharmaceuticals

Company Overview of Intas Pharmaceuticals Ltd.

Company Overview

Intas Pharmaceuticals Limited engages in the manufacture, marketing, distribution, and sale of finished pharmaceutical formulations, active pharmaceutical ingredients, medical appliances, and medical devices worldwide. The company provides products in various therapeutic areas, such as neurology, psychiatry, cardiology, diabetology, urology, nephrology, and pain management. It offers a portfolio of biosimilar products across microbial and mammalian cell culture products, such as Neukine, Erykine, Intalfa, Pegasta, Terifrac, Mabtas, and Folisurge, as well as operates in the field of plasma derived products and therapies. The company also provides scientific and prescription driven therapies c...

Chinubhai Centre

Off. Nehru Bridge

Ashram Road

Ahmedabad,  380009

India

Founded in 1985

Phone:

91 79 6652 3100

Fax:

91 79 2657 8862

Key Executives for Intas Pharmaceuticals Ltd.

Chief Executive Officer, Managing Director and Director
Age: 55
Founder and Chairman
Age: 83
Vice Chairman, Managing Director and Executive Non Independent Director
Age: 52
Managing Director and Executive Non Independent Director
Age: 57
Chief Finance Officer
Age: 52
Compensation as of Fiscal Year 2016.

Intas Pharmaceuticals Ltd. Key Developments

ChrysCapital To Reportedly Sell Stake In Intas Pharmaceutical

ChrysCapital has reportedly decided to offload its remaining stake in Intas Pharmaceuticals Ltd. and is holding discussions to dilute at least half of the stake shortly. "The company is looking to dilute around 3% now and has reached out to other bulge-bracket PE firms for the same. The other 3%, they will carry on to the next fund," one person familiar with the deal said.

Intas Mulls IPO

We will go in for an IPO at the appropriate time, because we believe we will have to provide an exit. Otherwise, we are very strong in balance sheet, we don't need more funds. We would be hoping for more debt. We are not averse to an IPO, but we are as good as listed now, Binish Chudgar and Vice Chairman, Managing Director of Intas Pharmaceuticals Ltd.

Intas Seeks Acquisitions

Intas Pharmaceuticals Ltd. is looking at more acquisitions in US and Europe to strengthen its three main areas of operations - oral solid tablet, oncology, and differentiated patent products, Intas Managing Director Binish Chudgar said.

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 26, 2016
RPG Life Sciences Limited, Biotech Unit in Ankleshwar, Gujarat
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intas Pharmaceuticals Ltd., please visit www.intaspharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.